17032

539871

THYROCARE

img img img img
No Data Available

THYROCARE TECH LTD Share Price Update

As of the latest trading session, THYROCARE TECH LTD is trading at ₹521.65, down by ₹-0.69 or -0.13% from its previous close. The stock has moved between ₹502.00 and ₹522.80 today. Over the past year, the stock has delivered a return of 55.06%. In the last month, it has returned 24.25%.

THYROCARE TECH LTD performance

Today’s low Today’s high
₹ 502.00 ₹ 522.80
₹ 519.50
52 week low 52 week high
₹ 291.36 ₹ 536.66
₹ 519.50
Open Price ₹ 517.40
Prev. Close ₹ 522.35
Volume (Shares) 445418.00
Total traded value ₹ 2313.94
Upper Circuit ₹ 626.80
Lower Circuit ₹ 417.90
info

Investment Returns

Over 1 Month 24.25% Over 3 Months 35.86% Over 6 Months 7.70% Over 1 Year 55.06%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

THYROCARE TECH LTD fundamentals


  • Market cap (Cr) 8,293.30
  • P/E Ratio (TTM) 55.84
  • Beta 0.61
  • Book Value / share 35.22
  • Return on equity 18.23%
  • EPS (TTM) 9.61
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 43.58
info icon alternate text
  • Market cap (Cr) 8,279.80
  • P/E Ratio (TTM) 55.84
  • Beta 0.56
  • Book Value / share 35.22
  • Return on equity 18.23%
  • EPS (TTM) 9.61
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 43.58
info icon alternate text

THYROCARE TECH LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 210.67
Operating Expense 152.41
Net Profit 43.58
Net Profit Margin (%) 20.68
Earnings Per Share (EPS) 2.75
EBITDA 76.35
Effective Tax Rate (%) 29.68
Particulars DEC 2025 (Values in Cr)
Revenue 182.48
Operating Expense 143.32
Net Profit 26.15
Net Profit Margin (%) 14.33
Earnings Per Share (EPS) 1.64
EBITDA 55.73
Effective Tax Rate (%) 28.59
Particulars SEP 2025 (Values in Cr)
Revenue 202.23
Operating Expense 143.62
Net Profit 43.03
Net Profit Margin (%) 21.27
Earnings Per Share (EPS) 8.12
EBITDA 71.19
Effective Tax Rate (%) 29.33
Particulars JUN 2025 (Values in Cr)
Revenue 178.89
Operating Expense 131.94
Net Profit 36.05
Net Profit Margin (%) 20.15
Earnings Per Share (EPS) 6.80
EBITDA 60.47
Effective Tax Rate (%) 29.18
Particulars MAR 2025 (Values in Cr)
Revenue 173.87
Operating Expense 130.60
Net Profit 21.95
Net Profit Margin (%) 12.62
Earnings Per Share (EPS) 4.08
EBITDA 60.18
Effective Tax Rate (%) 54.07
Particulars MAR 2026 (Values in Cr)
Revenue 774.27
Operating Expense 571.29
Net Profit 148.81
Net Profit Margin (%) 19.21
Earnings Per Share (EPS) 9.36
EBITDA 263.75
Effective Tax Rate (%) 29.27
Particulars MAR 2025 (Values in Cr)
Revenue 633.10
Operating Expense 495.23
Net Profit 95.78
Net Profit Margin (%) 15.12
Earnings Per Share (EPS) 17.95
EBITDA 200.36
Effective Tax Rate (%) 36.65
Particulars MAR 2024 (Values in Cr)
Revenue 524.02
Operating Expense 432.98
Net Profit 71.14
Net Profit Margin (%) 13.57
Earnings Per Share (EPS) 13.44
EBITDA 141.06
Effective Tax Rate (%) 27.57
Particulars MAR 2023 (Values in Cr)
Revenue 486.46
Operating Expense 410.78
Net Profit 56.97
Net Profit Margin (%) 11.71
Earnings Per Share (EPS) 10.77
EBITDA 117.39
Effective Tax Rate (%) 29.72
Particulars MAR 2022 (Values in Cr)
Revenue 561.53
Operating Expense 361.55
Net Profit 152.05
Net Profit Margin (%) 27.07
Earnings Per Share (EPS) 28.75
EBITDA 238.23
Effective Tax Rate (%) 26.68
Particulars MAR 2025 (Values in Cr)
Book Value / Share 92.81
ROE % 16.91
ROCE % 25.93
Total Debt to Total Equity 0.06
EBITDA Margin 29.74
Particulars MAR 2024 (Values in Cr)
Book Value / Share 93.03
ROE % 13.10
ROCE % 17.92
Total Debt to Total Equity 0.06
EBITDA Margin 25.97
Particulars MAR 2023 (Values in Cr)
Book Value / Share 97.37
ROE % 12.13
ROCE % 16.86
Total Debt to Total Equity 0.04
EBITDA Margin 25.09
Particulars MAR 2022 (Values in Cr)
Book Value / Share 99.54
ROE % 33.05
ROCE % 41.39
Total Debt to Total Equity 0.03
EBITDA Margin 40.79
Particulars MAR 2021 (Values in Cr)
Book Value / Share 80.82
ROE % 28.50
ROCE % 36.66
Total Debt to Total Equity 0.03
EBITDA Margin 37.12
Particulars MAR 2025 (Values in Cr)
Book Value / Share 91.19
ROE % 18.23
ROCE % 27.26
Total Debt to Total Equity 0.06
EBITDA Margin 31.73
Particulars MAR 2024 (Values in Cr)
Book Value / Share 90.58
ROE % 13.75
ROCE % 18.63
Total Debt to Total Equity 0.06
EBITDA Margin 27.14
Particulars MAR 2023 (Values in Cr)
Book Value / Share 94.86
ROE % 10.94
ROCE % 15.73
Total Debt to Total Equity 0.04
EBITDA Margin 24.60
Particulars MAR 2022 (Values in Cr)
Book Value / Share 98.43
ROE % 31.48
ROCE % 41.64
Total Debt to Total Equity 0.03
EBITDA Margin 42.55
Particulars MAR 2021 (Values in Cr)
Book Value / Share 84.26
ROE % 29.08
ROCE % 37.49
Total Debt to Total Equity 0.02
EBITDA Margin 38.59
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 54.48
Total Assets 692.75
Total Liabilities 692.75
Total Equity 547.05
Share Outstanding 5
Price to Book Ratio 7.46
Return on Assets (%) 13.20
Return on Capital (%) 16.73
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 39.89
Total Assets 643.88
Total Liabilities 643.88
Total Equity 527.63
Share Outstanding 5
Price to Book Ratio 6.54
Return on Assets (%) 10.98
Return on Capital (%) 12.88
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 28.47
Total Assets 632.72
Total Liabilities 632.72
Total Equity 535.22
Share Outstanding 5
Price to Book Ratio 4.53
Return on Assets (%) 10.19
Return on Capital (%) 12.05
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 13.91
Total Assets 607.66
Total Liabilities 607.66
Total Equity 526.57
Share Outstanding 5
Price to Book Ratio 7.86
Return on Assets (%) 28.98
Return on Capital (%) 33.45
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 15.73
Total Assets 545.80
Total Liabilities 545.80
Total Equity 427.28
Share Outstanding 5
Price to Book Ratio 10.72
Return on Assets (%) 20.73
Return on Capital (%) 26.48
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 51.98
Total Assets 676.35
Total Liabilities 676.35
Total Equity 537.10
Share Outstanding 5
Price to Book Ratio 7.46
Return on Assets (%) 14.16
Return on Capital (%) 17.83
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 34.10
Total Assets 620.27
Total Liabilities 620.27
Total Equity 513.81
Share Outstanding 5
Price to Book Ratio 6.54
Return on Assets (%) 11.46
Return on Capital (%) 13.33
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 16.39
Total Assets 611.87
Total Liabilities 611.87
Total Equity 521.04
Share Outstanding 5
Price to Book Ratio 4.53
Return on Assets (%) 9.31
Return on Capital (%) 10.93
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 12.00
Total Assets 597.17
Total Liabilities 597.17
Total Equity 520.70
Share Outstanding 5
Price to Book Ratio 7.86
Return on Assets (%) 25.46
Return on Capital (%) 29.2
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 7.67
Total Assets 527.79
Total Liabilities 527.79
Total Equity 445.46
Share Outstanding 5
Price to Book Ratio 10.72
Return on Assets (%) 22.69
Return on Capital (%) 26.89
Particulars MAR 2025 (Values in Cr)
Net Income 146.88
Cash from Operations 232.70
Cash from Investing -52.52
Cash from Financing -130.42
Net change in Cash 8.38
Free Cash Flow 277.59
Particulars MAR 2024 (Values in Cr)
Net Income 95.59
Cash from Operations 196.62
Cash from Investing -91.29
Cash from Financing -84.81
Net change in Cash -8.47
Free Cash Flow 258.20
Particulars MAR 2023 (Values in Cr)
Net Income 87.41
Cash from Operations 157.77
Cash from Investing -38.99
Cash from Financing -86.18
Net change in Cash 4.14
Free Cash Flow 201.42
Particulars MAR 2022 (Values in Cr)
Net Income 227.90
Cash from Operations 170.17
Cash from Investing -23.57
Cash from Financing -89.41
Net change in Cash 0.43
Free Cash Flow 208.00
Particulars MAR 2021 (Values in Cr)
Net Income 152.54
Cash from Operations 157.94
Cash from Investing -48.66
Cash from Financing -61.58
Net change in Cash 4.49
Free Cash Flow 184.63
Particulars MAR 2025 (Values in Cr)
Net Income 151.21
Cash from Operations 226.26
Cash from Investing -54.70
Cash from Financing -124.44
Net change in Cash 11.62
Free Cash Flow 273.21
Particulars MAR 2024 (Values in Cr)
Net Income 98.22
Cash from Operations 184.18
Cash from Investing -80.29
Cash from Financing -83.71
Net change in Cash -8.81
Free Cash Flow 227.45
Particulars MAR 2023 (Values in Cr)
Net Income 81.07
Cash from Operations 148.72
Cash from Investing -31.65
Cash from Financing -87.50
Net change in Cash 0.87
Free Cash Flow 169.84
Particulars MAR 2022 (Values in Cr)
Net Income 207.38
Cash from Operations 162.00
Cash from Investing -12.32
Cash from Financing -86.91
Net change in Cash 6.45
Free Cash Flow 202.41
Particulars MAR 2021 (Values in Cr)
Net Income 161.28
Cash from Operations 154.66
Cash from Investing -53.09
Cash from Financing -57.81
Net change in Cash 0.17
Free Cash Flow 193.76
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8099.40 59.53 12.29 116456.95 6680.00 8490.30
FORTIS MALAR HOSPITALS LIMITED 53.36 24.14 2.91 100.01 40.75 77.00
SHREE PACETRONIX LTD. 130.75 15.60 2.75 49.03 66.10 283.15
TRANSGENE BIOTEK LTD. 3.10 0.00 2.80 23.49 1.83 5.26
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8099.40 77.57 11.68 116456.95 6680.00 8490.30
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 39.30 0.00 -9.56 29.36 30.30 57.48
KOVAI MEDICAL CENTER & HOSPITA 5372.55 24.04 4.45 5877.57 5010.00 6725.00

THYROCARE TECH LTD shareholding pattern

Holding
12.71%
60.92%
5.36%
20.99%
100.0%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

THYROCARE TECH LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
521.05 -0.24 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 506.00
  • 26 Days 463.80
  • 10 Days 493.10
  • 50 Days 441.00
  • 12 Days 488.80
  • 100 Days 427.20
  • 20 Days 473.30
  • 200 Days 412.00
519.48 PIVOT
First Support 510.22 First Resistance 531.62 Second Support 498.08 Second Resistance 540.88 Third Support 488.82 Third Resistance 553.02
RSI 73.61 ADX 64.59 MACD 24.96 Williams % R -7.64 Commodity Channel Index (CCI) 161.43
Date 2026-06-01 Week 269573.00 Same Day 193760.00 Month 273756.00
1 Year 0.61 3 Year 0.55
Over 1 Month
24.25% down
Over 1 Year
55.06% down
Over 3 Months
35.86% down
Over 3 Years
50.91% down
Over 6 Months
7.70% down
Over 5 Years
8.50% down

THYROCARE TECH LTD Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
24 Oct 2025 7.0 Interim 24 Oct 2025 Equity shares
25 Jul 2025 21.0 Final 25 Jul 2025 Equity shares
16 Aug 2024 18.0 Final 16 Aug 2024 Equity shares
20 Apr 2023 18.0 Interim 20 Apr 2023 Equity shares
11 May 2022 15.0 Interim 12 May 2022 Equity shares
17 Jun 2021 15.0 Final 19 Jun 2021 Equity shares
12 Nov 2020 10.0 Interim 13 Nov 2020 Equity shares
21 Nov 2019 5.0 Interim 22 Nov 2019 Equity shares
14 Aug 2019 20.0 Final 18 Aug 2019 Equity shares
02 Aug 2018 5.0 Final 04 Aug 2018 Equity shares
15 Feb 2018 5.0 Interim 16 Feb 2018 Equity shares
03 Aug 2017 5.0 Final 06 Aug 2017 Equity shares
08 Feb 2017 5.0 Interim 09 Feb 2017 Equity shares
01 Sep 2016 2.5 Final 05 Sep 2016 Equity shares
Ex-Date Ex-Bonus Ratio
28 Nov 2025 28 Nov 2025 2:1
Dividend date Dividend amount Dividend type Record date Instrument type
24 Oct 2025 7.0 Interim 24 Oct 2025 Equity shares
25 Jul 2025 21.0 Final 25 Jul 2025 Equity shares
16 Aug 2024 18.0 Final 16 Aug 2024 Equity shares
20 Apr 2023 18.0 Interim 20 Apr 2023 Equity shares
11 May 2022 15.0 Interim 12 May 2022 Equity shares
17 Jun 2021 15.0 Final 19 Jun 2021 Equity shares
12 Nov 2020 10.0 Interim 13 Nov 2020 Equity shares
21 Nov 2019 5.0 Interim 22 Nov 2019 Equity shares
14 Aug 2019 20.0 Final 18 Aug 2019 Equity shares
02 Aug 2018 5.0 Final 04 Aug 2018 Equity shares
15 Feb 2018 5.0 Interim 16 Feb 2018 Equity shares
03 Aug 2017 5.0 Final 06 Aug 2017 Equity shares
08 Feb 2017 5.0 Interim 09 Feb 2017 Equity shares
01 Sep 2016 2.5 Final 05 Sep 2016 Equity shares
Ex-Date Ex-Bonus Ratio
28 Nov 2025 28 Nov 2025 2:1

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Thyrocare Technologies Ltd?

Answer Field

Thyrocare Technologies Ltd share price is for NSE ₹ 521.65 & for BSE ₹ 523.30 as on Jun 02 2026 03:30 PM.

What is the Market Cap of Thyrocare Technologies Ltd Share?

Answer Field

The market cap of Thyrocare Technologies Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 02 2026 03:30 PM.

What is the 52 Week High and Low of Thyrocare Technologies Ltd?

Answer Field

The 52 Week High and Low of Thyrocare Technologies Ltd for NSE is ₹ 536.66 and ₹ 291.36 and for BSE is ₹ 537.96 and ₹ 292.41.

What is 1 year return for Thyrocare Technologies Ltd?

Answer Field

The 1 year returns on the stock has been 55.06%.

What is the P/E Ratio of Thyrocare Technologies Ltd Share?

Answer Field

As on Jun 02 2026 03:30 PM the price-to-earnings (PE) ratio for Thyrocare Technologies Ltd share is 55.84.

What is the PB ratio of Thyrocare Technologies Ltd Share?

Answer Field

As on Jun 02 2026 03:30 PM, the price-to-book (PB) ratio for Thyrocare Technologies Ltd share is 35.22.

How to Buy Thyrocare Technologies Ltd Share?

Answer Field

You can trade in Thyrocare Technologies Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Thyrocare Technologies Ltd Share on Bajaj Broking App?

Answer Field

To buy Thyrocare Technologies Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Thyrocare Technologies Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|